3547 results for «221»
3547 results
Breakthrough studies: Key abstracts on PCI, TAVI and mitral valve repair
04 Oct 2024 – From AICT-AsiaPCR 2024
Discover the cutting-edge research and innovative solutions presented in the 'Best Abstracts of AICT-AsiaPCR 2024' session. This curated selection showcases the latest advancements in interventional cardiology, from groundbreaking comparisons of transcatheter mitral valve repair techniques to the impact of cerebral embolic protection devices in TAVI procedures....
Managing severe calcified LAD lesions in STEMI: Insights from three cases
04 Oct 2024 – From AICT-AsiaPCR 2024
Dive into this compelling presentation highlighting three challenging STEMI cases involving severe proximal LAD calcified stenosis. Witness the ingenuity of interventional strategies as the presenter explores how drug-coated balloons can be a viable alternative to stents in acute MI management. Don't miss this opportunity to deepen...
SWISS-APERO: a randomized trial of the amulet versus watchman FLX devices for left atrial appendage closure
04 Nov 2021
The SWISS-APERO is a prospective, investigator-initiated, randomized, multi-center, and clinical trial designed to compare the Amulet and Watchman (2.5 and FLX) devices in a head-to-head fashion.
Author
Mid-term echocardiographic outcomes following transapical mitral valve replacement: Updates from the Intrepid Pilot Study
19 Sep 2022
Pamela Gatto provides her take on the Intrepid Global Pilot Study which was presented by Renuka Jain at TCT Congress 2022.
Author
Post-TAVI cardiac arrest associated to acute coronary occlusion: facing the storm to gain calm
26 Jan 2024
Observe this TAVI case featuring pulseless electrical activity due to an unforeseen acute occlusion of the right coronary artery, and discover the strategies employed to address and resolve this critical complication.
Authors :
Five-year clinical and echocardiographic outcomes from the PARTNER 3 Low-Risk randomized trial
26 Oct 2023
Alex Sticchi provides his take on the 5-year outcomes from PARTNER 3 Low Risk which were presented by Martin B. Leon at TCT Congress 2023.
Author
PROSPECT II, COMBINE (OCT–FFR) and PROSPECT ABSORB: After revascularization of culprit lesions, assessment of coronary plaque size and composition matter!
17 Oct 2020
PROSPECT II, COMBINE (OCT–FFR) and PROSPECT ABSORB trials were presented at TCT Connect 2020. Hector Garcia-Garcia provides a summary of the key messages.
Author
